stockpil diagnosi headwind
run rate unaffect
channel check indic pipelin new diagnosi setup resuppli
program ensur maintain normal run rate
made minor adjust fx assumpt unchang
bullish street estim revenu con
devic growth mask growth estim ep con
estim chang detail tabl
new diagnosi could slow onward
previou estim assum new custom would get diagnos one
quarter follow channel check recent osa survey increas
three quarter assum potenti new patient lost
reschedul aggress loss factor suggest survey
expect advers quarter new custom diagnosi
start improv initi allevi bottleneck take effect
sharp increas mask accessori sale us sinc onset
howev expect short live assum higher suppli
revenu follow lower revenu order
brought forward higher unemploy rate give rise fewer insur also add
ventil sale tailwind
confid long-term growth osa industri
posit long-term growth outlook osa industri expect
develop result improv diagnosi pathway via
telemedicin diagnosi pcp increas home sleep test reiter buy
rate report result may
full definit iqmethod sm measur see page
employ non-u affili bofa registered/qualifi research analyst
finra rule
refer import disclosur inform certain bofa secur entiti take
respons inform herein particular jurisdict
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt naa
outsid equiti interest npat
chang work capit
 flow item int tax
 flow oper
oper
acquisit dispos invest
 flow invest
invest
 flow financ
financ
return capit employ
return equiti
iqmethod sm qualiti earn
full definit iqmethod sm measur see page
lead develop
manufactur medic devic mask cloud-
base softwar applic diagnos treat
manag respiratori disord headquart
san diego california focuss
connect health deliv better outcom
sleep apnea chronic obstruct pulmonari
outpac industri growth
market share place
everi market oper benefit
clinic data-captur proprietari
softwar boost therapi complianc
rate increas mask accessori growth
addit market develop
market activ target
moder sever osa suffer world-wide
price book valu
chang estim
made follow chang revenu estim
previou estim assum new custom would get
diagnos one quarter follow channel check osa survey see
global obstruct sleep apnea industri drag new osa
patient diagnosi april increas
next three quarter assum potenti new patient lost
reschedul aggress loss factor suggest
survey forecast slow diagnosi biggest impact
could extent allevi telehealth open
avail home sleep test increas wait will
test home
assum higher cpap mask accessori revenu follow
lower revenu order brought forward
higher unemploy rate give rise fewer insur
add devic revenu reflect ventil tailwind due
price object per share base dcf
valuat dcf use wacc termin growth rate beta
downsid risk po loss momentum saa busi market
educ effort achiev expect revenu growth reimburs
chang health ministri phi poor recept new product launch
technolog advanc competitor product fx chang
lyann harrison herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
iqmethod smi set bofa global research standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa global research
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
qualiti earn
